Almost two years since Merck's decision to recall the arthritis pill Vioxx, the legal liability from people who say Vioxx caused their heart attacks still casts a shadow over the legendary drug giant--even as Merck unveils some of its most promising new drugs in a decade.
Almost two years since Merck's (nyse: MRK - news - people ) decision to recall the arthritis pill Vioxx, the legal liability from people who say Vioxx caused their heart attacks still casts a shadow over the legendary drug giant--even as Merck unveils some of its most promising new drugs in a decade.